https://doi.org/10.4081/hmr.v2i7.421

What will be the future after R-CHOP in patient with DLBCL?

Vol. 2 No. 7: New Insights in Hematology, Venice (Italy), May 14-17, 2006
Published: June 8, 2009
Abstract Views: 148
PDF: 222
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

B Coiffier
support@pagepress.org
R-CHOP (combination of rituximab plus standard CHOP regimen) has become the standard for treating patients with diffuse large B-cell lymphoma (DLBCL). This combination of 8 cycles of chemo-immunotherapy every 3 weeks was demonstrated as superior to CHOP alone in several studies in different settings. It allows increasing the CR rate, decreasing the relapse rate, prolonging event-free survival, progression-free survival, disease-free survival, and overall survival. This is true in young and elderly patients, in patients with low- or high-risk lymphoma. However, several questions remain for improving on these results.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Coiffier, B. (2009). What will be the future after R-CHOP in patient with DLBCL?. Hematology Meeting Reports (formerly Haematologica Reports), 2(7). https://doi.org/10.4081/hmr.v2i7.421
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).